Making a difference in cardiovascular care
Cardiovascular disease (CVD) covers a range of conditions affecting the heart and circulatory system. These include coronary heart disease, angina, heart attack and stroke.
Countries in Africa and the Middle East bear a heavy burden from cardiovascular disease. The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles. Patients in Africa and the Middle East present with myocardial infarction at a younger age, on average, compared with patients elsewhere. The projected future burden of mortality from coronary heart disease in Africa and the Middle East is set to outstrip that observed in other geographical regions.(Source: NCBI)
Recent detailed nationally representative epidemiological data are lacking for many countries, and high proportions of transient expatriate workers in countries such as Saudi Arabia and the United Arab Emirates complicate the construction of such datasets. However, the development of national registries in some countries is beginning to reveal the nature of coronary heart disease. Improving lifestyles (reducing calorie intake and increasing physical activity) in patients in the region will be essential, although cultural and environmental barriers will render this difficult. Appropriate prescribing of pharmacologic treatments is essential in the prevention and management of cardiovascular disease.
Roche has a long history of expertise in this field, with a track record in providing therapies and diagnostic tools to support the growing number of people with heart disease and the professionals who care for them. Today, Roche is focused on the diagnosis, monitoring and treatment of cardiovascular disease.